• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Sciclone Pharmaceuticals Inc

+ Add to Watchlist

SCLN:US

4.5400 USD 0.0700 1.57%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Sciclone Pharmaceuticals Inc (SCLN)

Open: 4.4500 Day's Range: 4.4100 - 4.5900 Volume: 147,360
Previous Close: 4.4700 52wk Range: 4.2400 - 6.3000 1-Yr Rtn: +1.57%

Stock Chart for SCLN

No chart data available.
  • SCLN:US 4.5400
  • 1D
  • 1M
  • 1Y
4.4700
Interactive SCLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SCLN

Current P/E Ratio (ttm) 18.9869
Estimated P/E(12/2014) 13.3529
Relative P/E vs. SPX 1.1041
Earnings Per Share (USD) (ttm) 0.2391
Est. EPS (USD) (12/2014) 0.3400
Est. PEG Ratio -
Market Cap (M USD) 235.89
Shares Outstanding (M) 51.96
30 Day Average Volume 259,112
Price/Book (mrq) 1.6219
Price/Sale (ttm) 1.9137
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SCLN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SCLN

SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company's products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.

Friedhelm BlobelPresident/CEOHong ZhaoCEO:China Operations
Wilson W CheungSenior VP:Finance/CFOCharles MengVP:Compliance/General Counsel
More Company Profile & Key Executives for SCLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil